Press Releases

CTLA-4 Inhibitors Market is Forecasted to Hit US$ 11.4 Bn By 2031 | CAGR 17.2%

The CTLA-4 Inhibitors Market belongs to the pharmaceutical industry, specifically the field of cancer immunotherapy. These drugs are designed to enhan

  • Date: 11 Apr, 2024
  • Author: Sagar Karlekar
Cough in Idiopathic Pulmonary Fibrosis (IPF) Market is Forecasted to Hit US$ 6.2 Bn By 2031 | CAGR 8.7%

The Cough in Idiopathic Pulmonary Fibrosis (IPF) Market falls under the pharmaceutical industry, specifically focused on developing and providing trea

  • Date: 11 Apr, 2024
  • Author: Sagar Karlekar
Connective Tissue Growth Factor (CTGF) Inhibitors Market is Forecasted to Hit US$ 1,896.1 Mn By 2031 | CAGR 41.2%

The Connective Tissue Growth Factor (CTGF) Inhibitors Market falls under the pharmaceutical industry and is focused on developing and commercializing

  • Date: 11 Apr, 2024
  • Author: Sagar Karlekar
Complement 3 Glomerulopathy Market is Forecasted to Hit US$ 1,014.2 Mn By 2031 | CAGR 22.5%

Complement 3 Glomerulopathy Market Expected to Achieve US$ 1,014.2 Mn by 2031, growing at a CAGR of  CAGR 22.5% from 2024 to 2031. The Complement

  • Date: 10 Apr, 2024
  • Author: Sagar Karlekar
Complicated Urinary Tract Infections Market is Forecasted to Hit US$ 6.8 Bn By 2031 | CAGR 11.8%

Complicated Urinary Tract Infections Market Expected to achieve US$ 6.8 Bn by 2031, growing at a CAGR of 11.8% from 2024 to 2031. The Complicated Urin

  • Date: 10 Apr, 2024
  • Author: Sagar Karlekar
Complement Inhibitors (C3/C5) Market is Forecasted to Hit US$ 9.9 Bn By 2031 | CAGR 15.2%

The Complement Inhibitors (C3/C5) Market falls under the pharmaceuticals industry, specifically within the immunology/rheumatology segment. These drug

  • Date: 10 Apr, 2024
  • Author: Sagar Karlekar
Cervical Cancer Market is Forecasted to Hit US$ 16.2 Bn By 2031 | CAGR 9.6%

The Global Cervical Cancer Market, encompassing pharmaceuticals, medical devices, and diagnostic solutions, is witnessing remarkable growth driven by

  • Date: 09 Apr, 2024
  • Author: Sagar Karlekar
Acute Kidney Injury (AKI) Market is Forecasted to Hit US$ 1,929.5 Mn By 2031 | CAGR 9.7%

The Global Acute Kidney Injury (AKI) Market, a crucial segment of the pharmaceutical industry, is poised for substantial growth in the coming years. A

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Amyotrophic Lateral Sclerosis (ALS) Market is Forecasted to Hit US$ 1,330.9 Mn By 2031 | CAGR 9.8%

The Global Amyotrophic Lateral Sclerosis (ALS) Market is expected to reach US$ 1,330.9 million by 2031, exhibiting a remarkable growth rate of 9.8% du

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
PD-1 Resistant Head and Neck Cancer (HNC) Market Expected to Achieve US$ 1,928.6 Million by 2031 | CAGR 41.5%

The PD-1 Resistant Head and Neck Cancer (HNC) Market is a part of the pharmaceutical industry, focused on developing novel therapies for patients with

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Alport Syndrome Market is Forecasted to Hit US$ 1,313.9 Mn By 2031 | CAGR 11.5%

The Alport Syndrome Market Expected to Achieve US$ 1,313.9 Mn by 2031, growing at a robust CAGR of 11.5% during the forecast period of 2024-2031.

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Powered Surgical Instrument Market Expected to Achieve US$ 7.5 Bn by 2031 | CAGR 11.2%

The Global Powered Surgical Instrument Market, part of the broader medical devices industry, is witnessing significant growth driven by technological

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Solid Tumor Therapeutics Market is Forecasted to Hit US$ 302.8 Bn By 2031 | CAGR 10.2%

The Solid Tumor Therapeutics Market Expected to Achieve US$ 302.8 Bn by 2031 exhibiting a robust CAGR 10.2% during the forecast period from

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Molecular Weight Marker Market is Forecasted to Hit US$ 2.5 Bn By 2031 | CAGR 7.2%

The Global Molecular Weight Marker Market is expected to reach US$ 2.5 Bn in 2031, with a growth rate of 9.8%. Molecular weight markers are essential

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar
Small Molecule Drug Discovery Market is Forecasted to Hit US$ 68.1 Bn By 2031 | CAGR 8.6%

The Small Molecule Drug Discovery Market is a crucial segment of the pharmaceutical industry, focused on the research, development, and commercializat

  • Date: 07 Apr, 2024
  • Author: Sagar Karlekar